Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients

Artificial intelligence (AI) is increasingly being used to improve patient care and management. In this paper, we propose explainable AI (XAI) models for predicting severe hypoglycemia (SH) and diabetic ketoacidosis (DKA) episodes in adults with type 1 diabetes (T1D) and relapses in adults with rela...

Full description

Bibliographic Details
Main Authors: Anusha Ihalapathirana, Konstantina Chalkou, Pekka Siirtola, Satu Tamminen, Gunjan Chandra, Pascal Benkert, Jens Kuhle, Georgia Salanti, Juha Röning
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Informatics in Medicine Unlocked
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352914823001958
_version_ 1797646592062259200
author Anusha Ihalapathirana
Konstantina Chalkou
Pekka Siirtola
Satu Tamminen
Gunjan Chandra
Pascal Benkert
Jens Kuhle
Georgia Salanti
Juha Röning
author_facet Anusha Ihalapathirana
Konstantina Chalkou
Pekka Siirtola
Satu Tamminen
Gunjan Chandra
Pascal Benkert
Jens Kuhle
Georgia Salanti
Juha Röning
author_sort Anusha Ihalapathirana
collection DOAJ
description Artificial intelligence (AI) is increasingly being used to improve patient care and management. In this paper, we propose explainable AI (XAI) models for predicting severe hypoglycemia (SH) and diabetic ketoacidosis (DKA) episodes in adults with type 1 diabetes (T1D) and relapses in adults with relapsing-remitting multiple sclerosis (RRMS). We follow a three-step process in this study: (1) develop baseline machine learning (ML) models, (2) improve the models using ReliefF feature selection technique, and develop sex-stratified models, (3) explain the models and their results using SHapley Additive exPlanations (SHAP). We built six ML models (XGBoost, LightGBM, CatBoost, AdaBoost, random forest, and linear regression) for all scenarios. Applying the ReliefF feature selection led to improved model performance in predicting all outcomes compared to the baseline models. Additionally, sex-stratified models further improved the prediction of SH episodes and relapses. The F1 scores for predicting SH episodes in male and female patients were 84.07% and 84.95%, respectively, and the DKA prediction model achieved an F1 score of 78.67%. The proposed relapse prediction models outperformed existing models with F1 scores of 84.55% (males) and 76.11% (females), and ROCs of 70.26% (males) and 69.05% (females). Our results highlight the importance of considering sex differences, socioeconomic factors, and physical and mental health in medical outcome prediction. Boosting ML algorithms were found to be effective in detecting SH and DKA in T1D patients and relapses in RRMS patients compared to conventional tree-based ML and statistical models.
first_indexed 2024-03-11T15:04:49Z
format Article
id doaj.art-7f195375cdf64be5aa582f9f95e02d8e
institution Directory Open Access Journal
issn 2352-9148
language English
last_indexed 2024-03-11T15:04:49Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Informatics in Medicine Unlocked
spelling doaj.art-7f195375cdf64be5aa582f9f95e02d8e2023-10-30T06:05:11ZengElsevierInformatics in Medicine Unlocked2352-91482023-01-0142101349Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patientsAnusha Ihalapathirana0Konstantina Chalkou1Pekka Siirtola2Satu Tamminen3Gunjan Chandra4Pascal Benkert5Jens Kuhle6Georgia Salanti7Juha Röning8Biomimetics and Intelligent Systems Group, Faculty of Information Technology and Electrical Engineering, University of Oulu, Oulu, FI-90014, Finland; Corresponding author.Institute of Social and Preventive Medicine, University of Bern, Bern, CH-3012, SwitzerlandBiomimetics and Intelligent Systems Group, Faculty of Information Technology and Electrical Engineering, University of Oulu, Oulu, FI-90014, FinlandBiomimetics and Intelligent Systems Group, Faculty of Information Technology and Electrical Engineering, University of Oulu, Oulu, FI-90014, FinlandBiomimetics and Intelligent Systems Group, Faculty of Information Technology and Electrical Engineering, University of Oulu, Oulu, FI-90014, FinlandClinical Trial Unit, Department of Clinical Research, University Hospital Basel, University of Basel, Basel, 4001, SwitzerlandMultiple Sclerosis Centre, Neurologic Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, 4001, Switzerland; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), University Hospital and University of Basel, Basel, 4001, SwitzerlandInstitute of Social and Preventive Medicine, University of Bern, Bern, CH-3012, SwitzerlandBiomimetics and Intelligent Systems Group, Faculty of Information Technology and Electrical Engineering, University of Oulu, Oulu, FI-90014, FinlandArtificial intelligence (AI) is increasingly being used to improve patient care and management. In this paper, we propose explainable AI (XAI) models for predicting severe hypoglycemia (SH) and diabetic ketoacidosis (DKA) episodes in adults with type 1 diabetes (T1D) and relapses in adults with relapsing-remitting multiple sclerosis (RRMS). We follow a three-step process in this study: (1) develop baseline machine learning (ML) models, (2) improve the models using ReliefF feature selection technique, and develop sex-stratified models, (3) explain the models and their results using SHapley Additive exPlanations (SHAP). We built six ML models (XGBoost, LightGBM, CatBoost, AdaBoost, random forest, and linear regression) for all scenarios. Applying the ReliefF feature selection led to improved model performance in predicting all outcomes compared to the baseline models. Additionally, sex-stratified models further improved the prediction of SH episodes and relapses. The F1 scores for predicting SH episodes in male and female patients were 84.07% and 84.95%, respectively, and the DKA prediction model achieved an F1 score of 78.67%. The proposed relapse prediction models outperformed existing models with F1 scores of 84.55% (males) and 76.11% (females), and ROCs of 70.26% (males) and 69.05% (females). Our results highlight the importance of considering sex differences, socioeconomic factors, and physical and mental health in medical outcome prediction. Boosting ML algorithms were found to be effective in detecting SH and DKA in T1D patients and relapses in RRMS patients compared to conventional tree-based ML and statistical models.http://www.sciencedirect.com/science/article/pii/S2352914823001958Explainable AIT1DRRMSSevere hypoglycemiaDiabetic ketoacidosisRelapses
spellingShingle Anusha Ihalapathirana
Konstantina Chalkou
Pekka Siirtola
Satu Tamminen
Gunjan Chandra
Pascal Benkert
Jens Kuhle
Georgia Salanti
Juha Röning
Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients
Informatics in Medicine Unlocked
Explainable AI
T1D
RRMS
Severe hypoglycemia
Diabetic ketoacidosis
Relapses
title Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients
title_full Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients
title_fullStr Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients
title_full_unstemmed Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients
title_short Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients
title_sort explainable artificial intelligence to predict clinical outcomes in type 1 diabetes and relapsing remitting multiple sclerosis adult patients
topic Explainable AI
T1D
RRMS
Severe hypoglycemia
Diabetic ketoacidosis
Relapses
url http://www.sciencedirect.com/science/article/pii/S2352914823001958
work_keys_str_mv AT anushaihalapathirana explainableartificialintelligencetopredictclinicaloutcomesintype1diabetesandrelapsingremittingmultiplesclerosisadultpatients
AT konstantinachalkou explainableartificialintelligencetopredictclinicaloutcomesintype1diabetesandrelapsingremittingmultiplesclerosisadultpatients
AT pekkasiirtola explainableartificialintelligencetopredictclinicaloutcomesintype1diabetesandrelapsingremittingmultiplesclerosisadultpatients
AT satutamminen explainableartificialintelligencetopredictclinicaloutcomesintype1diabetesandrelapsingremittingmultiplesclerosisadultpatients
AT gunjanchandra explainableartificialintelligencetopredictclinicaloutcomesintype1diabetesandrelapsingremittingmultiplesclerosisadultpatients
AT pascalbenkert explainableartificialintelligencetopredictclinicaloutcomesintype1diabetesandrelapsingremittingmultiplesclerosisadultpatients
AT jenskuhle explainableartificialintelligencetopredictclinicaloutcomesintype1diabetesandrelapsingremittingmultiplesclerosisadultpatients
AT georgiasalanti explainableartificialintelligencetopredictclinicaloutcomesintype1diabetesandrelapsingremittingmultiplesclerosisadultpatients
AT juharoning explainableartificialintelligencetopredictclinicaloutcomesintype1diabetesandrelapsingremittingmultiplesclerosisadultpatients